FDA Panel Mulls COVID Booster Issues Despite 'Insufficient' Data

(MedPage Today) -- All the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) could agree about on Wednesday in terms of a plan for COVID boosters is that they need more data.
The 8-hour meeting, broadcast over YouTube...